Sanara MedTech (SMTI) Return on Capital Employed (2011 - 2026)
Sanara MedTech's (SMTI) quarterly Return on Capital Employed came in at 11.51% in Q1 2026, up 1027.0% YoY from 1.02% in Q1 2025, and up 28.38% on a QoQ basis from 8.96% in Q4 2025.
Sanara MedTech (SMTI) Return on Capital Employed (2011 - 2026) Analysis & Trends
Sanara MedTech (SMTI) has 14 years of Return on Capital Employed data on file, last reported at 11.51% in Q1 2026.
- Quarterly Return on Capital Employed rose 1027.0% year-over-year to 11.51% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 11.51% (up 1027.0% YoY) and the FY2025 annual result came in at 11.8%, up 989.0% from the prior year.
- Return on Capital Employed improved to 11.51% in Q1 2026, from 8.96% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 11.51% in Q1 2026 to a low of 34.34% in Q2 2022.
- A 5-year average of 9.74% and a median of 7.6% in 2024 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2022 — Return on Capital Employed sank 2220 bps — and 2023, when it jumped 1882 bps.
- Tracing SMTI's Return on Capital Employed over 5 years: stood at 25.84% in 2022, then soared by 73 bps to 7.01% in 2023, then surged by 73 bps to 1.89% in 2024, then surged by 575 bps to 8.96% in 2025, then grew by 28 bps to 11.51% in 2026.
- The last three Return on Capital Employed figures came in at 11.51% (Q1 2026), 8.96% (Q4 2025), and 8.87% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 18.58% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 6.00% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 28.11% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 25.22% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 5.57% |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 19.71% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 19.76% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 4.68% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 3.28% |
| 10 | Sanara MedTech | 297.82 Mn | 297.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.51% |
| Dec 31, 2025 | 8.96% |
| Sep 30, 2025 | 8.87% |
| Jun 30, 2025 | 4.64% |
| Mar 31, 2025 | 1.24% |
| Dec 31, 2024 | -1.89% |
| Sep 30, 2024 | -5.80% |
| Jun 30, 2024 | -9.16% |
| Mar 31, 2024 | -7.60% |
| Dec 31, 2023 | -7.01% |
| Sep 30, 2023 | -11.73% |
| Jun 30, 2023 | -16.55% |
| Mar 31, 2023 | -21.96% |
| Dec 31, 2022 | -25.84% |
| Sep 30, 2022 | -28.60% |
| Jun 30, 2022 | -34.34% |
| Mar 31, 2022 | -30.30% |
| Dec 31, 2021 | -23.69% |
| Sep 30, 2021 | -14.08% |
| Jun 30, 2021 | -12.14% |